Honeywell unveils aclar edge innovative bottles and vials for oral liquid and sterile injectables
Innovative Aclar® EdgeTM technology provides a safer alternative to glass, minimizing product loss resulting from breakage
Honeywell announced Aclar Edge, an innovative pharmaceutical packaging solution for oral liquids for human health and sterile injectables for animal health applications. Designed with Honeywell’s novel and proprietary multi-layer extrusion blow molding technology, Aclar Edge bottles and vials preserve shelf-life and efficacy for a large variety of challenging liquid dosage forms while significantly improving user safety during the handling and administration.
Aclar Edge bottles and vials provide a moisture barrier performance that is comparable with glass and an enhanced oxygen barrier compared to other polymeric containers. In addition, Aclar Edge offers impact resistance and up to 75 per cent weight reduction versus glass. Aclar Edge offers significant operational advantages by eliminating glass breakage, minimizing drug particulate contamination and reducing transportation cost. And unlike most plastic bottles used for liquids, Aclar Edge significantly reduces the risk of leachables from the container closure systems.
“Glass bottles pose many challenges to the pharmaceutical industry as they are susceptible to cracking and breaking, inorganic leachables, and glass particulates. Aclar Edge is a novel technology that overcomes these issues and can improve drug product stability, purity and ultimately patient safety. It is going to benefit a spectrum of customers across the globe and especially here in India with the country being a major producer, consumer and exporter of pharmaceutical products,” said Rajarshi Datta, general manager, Honeywell Advanced Materials, Honeywell India.
Aclar Edge bottles and vials range in sizes from 100 ml to 500 ml and can be configured in threaded or crimped finish; commercial production will start in Q4 2020 for non-sterilized or gamma-sterilized formats.
Pre-production samples of Aclar Edge are available now for customer evaluation.
For more than three decades, Honeywell’s solutions and services have helped the world’s leading drug manufacturers and biomedical firms enhance operations and build more effective, profitable businesses and improve patients’ lives. Honeywell’s cutting-edge technologies, specialty chemicals and advanced materials help create the future of medicine and medical devices, improve information transparency and tracking to support timely, accurate and safe healthcare delivery, and streamline manufacturing and distribution of medical products to patients.